Inventiva S.A (IVA) | Financial Analysis & Statements
Inventiva S.A. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2021Income Metrics
Revenue
65.0K
Operating Income
-13.7M
-21,032.31%
Net Income
-14.3M
-21,992.31%
EPS (Diluted)
$-0.37
Balance Sheet Metrics
Total Assets
249.5M
Total Liabilities
278.0M
Shareholders Equity
-28.5M
Cash Flow Metrics
Operating Cash Flow
-24.5M
Free Cash Flow
-12.1M
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2021
Annual Income Flow
2025
Inventiva S.A Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 4.5M | 9.2M | 17.5M | 12.2M | 4.2M |
| Cost of Goods Sold | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses | |||||
| Research & Development | 87.0M | 90.9M | 110.0M | 60.5M | 48.5M |
| Selling, General & Administrative | 53.9M | 17.1M | 15.6M | 15.3M | 11.3M |
| Other Operating Expenses | -3.8M | -5.5M | -5.7M | -6.9M | -6.5M |
| Total Operating Expenses | 137.1M | 102.5M | 119.9M | 68.8M | 53.3M |
| Operating Income | -132.9M | -94.0M | -102.7M | -56.9M | -51.2M |
| Operating Margin % | -2,964.2% | -1,021.8% | -587.4% | -466.8% | -1,220.2% |
| Non-Operating Items | |||||
| Interest Income | 2.9M | 1.1M | 991.0K | 390.0K | 57.0K |
| Interest Expense | 33.6M | 12.2M | 5.2M | 707.0K | 138.0K |
| Other Non-Operating Income | -190.6M | -78.8M | -2.9M | 2.9M | 2.0M |
| Pre-tax Income | -354.1M | -183.9M | -109.8M | -54.3M | -49.3M |
| Income Tax | 22.0K | 313.0K | 607.0K | -20.0K | 364.0K |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | -354.1M | -184.2M | -110.4M | -54.3M | -49.6M |
| Net Margin % | -7,899.5% | -2,002.8% | -631.8% | -445.6% | -1,183.6% |
| Key Metrics | |||||
| EBITDA | -127.1M | -88.0M | -101.1M | -54.8M | -50.9M |
| EPS (Basic) | $-1.90 | $-3.08 | $-2.43 | $-1.31 | $-1.27 |
| EPS (Diluted) | $-1.90 | $-3.08 | $-2.43 | $-1.31 | $-1.27 |
| Basic Shares Outstanding | 186388421 | 59778701 | 45351799 | 41449732 | 34479723 |
| Diluted Shares Outstanding | 186388421 | 59778701 | 45351799 | 41449732 | 34479723 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Inventiva S.A Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 99.3M | 96.6M | 26.9M | 86.7M | 86.6M |
| Short-term Investments | 131.6M | 0 | 70.0K | 1.0M | 8.8M |
| Accounts Receivable | 2.0M | 531.0K | 3.8M | 0 | 4.0M |
| Inventory | 0 | 0 | 417.0K | 373.0K | 392.0K |
| Other Current Assets | 526.0K | 349.0K | 421.0K | 282.0K | 763.0K |
| Total Current Assets | 244.5M | 111.5M | 48.2M | 106.4M | 115.6M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 11.5M | 10.7M | 10.5M | 6.8M | 1.6M |
| Goodwill | 183.0K | 48.0K | 542.0K | 568.0K | 770.0K |
| Intangible Assets | 183.0K | 48.0K | 542.0K | 568.0K | 770.0K |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 191.0K | 217.0K | 225.0K | 65.0K | -2.0K |
| Total Non-Current Assets | 5.0M | 7.5M | 21.4M | 9.6M | 6.4M |
| Total Assets | 249.5M | 119.0M | 69.6M | 116.0M | 122.0M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 26.0M | 32.9M | 37.7M | 19.4M | 14.6M |
| Short-term Debt | 32.3M | 5.9M | 5.3M | 5.9M | 1.3M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 1.0K | 73.4M | - | -1.0K | 1.0K |
| Total Current Liabilities | 77.4M | 120.7M | 50.2M | 30.7M | 22.9M |
| Non-Current Liabilities | |||||
| Long-term Debt | 27.6M | 48.5M | 32.2M | 28.7M | 8.8M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 52.8M | 30.2M | 7.4M | -2.0K | -2.0K |
| Total Non-Current Liabilities | 200.7M | 104.9M | 51.4M | 39.8M | 10.3M |
| Total Liabilities | 278.0M | 225.6M | 101.6M | 70.5M | 33.1M |
| Equity | |||||
| Common Stock | 1.9M | 957.0K | 521.0K | 421.0K | 409.0K |
| Retained Earnings | -354.1M | -184.2M | -110.4M | -54.3M | -49.6M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | -28.5M | -106.6M | -32.0M | 45.5M | 88.9M |
| Key Metrics | |||||
| Total Debt | 59.9M | 54.3M | 37.5M | 34.5M | 10.1M |
| Working Capital | 167.1M | -9.2M | -2.0M | 75.7M | 92.7M |
Balance Sheet Composition
Inventiva S.A Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -354.1M | -184.2M | -110.4M | -54.3M | -49.6M |
| Depreciation & Amortization | 3.2M | 5.2M | 2.6M | 1.7M | -1.3M |
| Stock-Based Compensation | 26.8M | 3.6M | 4.0M | 2.2M | 2.1M |
| Working Capital Changes | -790.0K | 5.0M | -2.7M | 2.2M | -6.6M |
| Operating Cash Flow | -114.1M | -87.4M | -109.1M | -52.4M | -58.0M |
| Investing Activities | |||||
| Capital Expenditures | -247.0K | -333.0K | -409.0K | -520.0K | -445.0K |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | -132.9M | - | -8.3M | -1.0K | -1.3M |
| Investment Sales | - | 9.1M | 978.0K | 9.4M | - |
| Investing Cash Flow | -133.2M | 8.7M | -7.7M | 8.9M | -1.8M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | - | - |
| Debt Issuance | 0 | 24.9M | 0 | 30.2M | 0 |
| Debt Repayment | -6.0M | -5.0M | -4.1M | -1.8M | -28.0K |
| Financing Cash Flow | 183.3M | 87.4M | 29.1M | 67.5M | 25.4M |
| Free Cash Flow | -105.1M | -86.3M | -82.2M | -45.5M | -48.2M |
| Net Change in Cash | -63.9M | 8.7M | -87.8M | 24.0M | -34.3M |
Cash Flow Trend
Inventiva S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-2.75
Forward P/E
-4.25
Price to Book
-6.90
Price to Sales
165.85
PEG Ratio
-4.25
Profitability Ratios
Profit Margin
0.00%
Operating Margin
-6,710.69%
Return on Equity
1,241.63%
Return on Assets
-45.08%
Financial Health
Current Ratio
3.16
Debt to Equity
-9.54
Beta
0.95
Per Share Data
EPS (TTM)
$-2.23
Book Value per Share
$-0.07
Revenue per Share
$0.04
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| IVA | 1.1B | -2.75 | -6.90 | 1,241.63% | 0.00% | -9.54 |
| Vertex | 109.4B | 28.40 | 5.92 | 22.54% | 32.94% | 10.91 |
| Regeneron | 81.0B | 18.00 | 2.45 | 14.86% | 31.41% | 9.51 |
| Recursion | 1.9B | -2.44 | 1.64 | -59.54% | 4.45% | 6.89 |
| Capricor | 2.0B | -15.61 | 6.62 | -46.56% | 0.00% | 4.75 |
| Zymeworks | 2.0B | 3.79 | 7.32 | -26.72% | -76.56% | 6.80 |
Financial data is updated regularly. All figures are in the company's reporting currency.






